-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, F26EqOQjnxgZhvXa6LmeDaMCxgS2mPbdNfmYDHyFIJRpeZ8D/oFKWWMEwCVcHf7h +Srn3tzFrACpaXwq3O3p2g== 0001252877-11-000001.txt : 20110217 0001252877-11-000001.hdr.sgml : 20110217 20110217110646 ACCESSION NUMBER: 0001252877-11-000001 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20101231 FILED AS OF DATE: 20110217 DATE AS OF CHANGE: 20110217 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SyntheMed, Inc. CENTRAL INDEX KEY: 0000889428 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 141745197 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 MIDDLESEX ESSEX TURNPIKE, SUITE 210 CITY: ISELIN STATE: NJ ZIP: 08830 BUSINESS PHONE: 7324041117 MAIL ADDRESS: STREET 1: 200 MIDDLESEX ESSEX TURNPIKE, SUITE 210 CITY: ISELIN STATE: NJ ZIP: 08830 FORMER COMPANY: FORMER CONFORMED NAME: LIFE MEDICAL SCIENCES INC DATE OF NAME CHANGE: 19930328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FRANKEL BARRY R CENTRAL INDEX KEY: 0001252877 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 000-20580 FILM NUMBER: 11619770 MAIL ADDRESS: STREET 1: C/O LIFE MEDICAL SCIENCES INC STREET 2: P O BOX 219 CITY: LITTLE SILVER STATE: NJ ZIP: 07739 5 1 primary_doc.xml PRIMARY DOCUMENT X0303 5 2010-12-31 0 0 1 0000889428 SyntheMed, Inc. symd 0001252877 FRANKEL BARRY R C/O SYNTHEMED, INC 200 MIDDLESEX ESSEX TURNPIKE ISELIN NJ 08830 1 0 0 0 Common Stock 2010-03-31 4 A 0 L 32500 0.1 A 294405 D Common Stock 2010-06-30 4 A 0 L 45455 0.11 A 294405 D Common Stock 2010-09-30 4 A 0 L 125000 0.04 A 294405 D Common Stock 2010-12-31 4 A 0 L 25000 0.2 A 294405 D Reflects the portion of the reporting person's quarterly board fees for the quarter ended on the referenced transaction date which, in accordance with approval by the Board of Directors, is payable in shares of common stock, based on the fair market value of the shares on the last trading day of the quarter, as reflected by the closing price on that date: $.10 on March 31, $.11 on June 30, $.04 on September 30 and $.20 on December 31. Barry R. Frankel, by Keith Moskowitz, attorney-in-fact 2011-02-17 -----END PRIVACY-ENHANCED MESSAGE-----